Predictors of coronary in-stent restenosis:: Importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors

被引:41
作者
Jorgensen, E
Kelbæk, H
Helqvist, S
Jensen, GVH
Saunamäki, K
Kastrup, J
Havndrup, O
Bundgaard, H
Madsen, JK
Christiansen, M
Andersen, PS
Reiber, JHC
机构
[1] Rigshosp, Dept Cardiol, Cardiac Catheterizat Lab 2014, Ctr Heart, DK-2100 Copenhagen O, Denmark
[2] Statens Serum Inst, Dept Clin Biochem, DK-2300 Copenhagen, Denmark
[3] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands
关键词
D O I
10.1016/S0735-1097(01)01580-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES This study aimed to clarify the role of the angiotensin-converting enzyme (ACE) gene polymorphism in the development of in-stent restenosis. BACKGROUND In-stent restenosis occurs after treatment of coronary artery stenosis in 12% to 32% of coronary interventions with stents. Experimental and clinical studies have suggested that the deletion/insertion (D/I) polymorphism of the ACE gene plays a role in this. METHODS Quantitative coronary angiography before, immediately after and six months after stent implantation were compared in 369 patients, in whom IM typing of the ACE gene was performed. RESULTS At follow-up we found no differences between the three genotypes in minimal lumen diameter (homozygotes with two deletion alleles in the ACE gene [DD], 2.20 mm; heterozygotes with one deletion and one insertion allele in the ACE gene [DI], 2.19 mm; and homozygotes with two insertion alleles in the ACE gene [II], 2.25 mm). The corresponding diameter stenoses were: DD: 25%, DI: 27%, II: 27% (p = NS), and the frequency Of restenosis (>50% diameter stenosis) was: DD: 15.7%, DI: 11.0% and II: 16.4% (p = INS). Logistic regression analysis identified diabetes (odds ratio [OR]: 3.0, 95% confidence interval [Cl]: 1.0 to 8.7), lesion length (OR: 1.1, 95% Cl: 1.01 to 1.30) and minimal lumen diameter immediately after the intervention (OR: 0.3, 95% CI: 0.14 to 0.85) as predictors of ill-stent restenosis. In a post hoc analysis of patients treated versus those not treated with all ACE-inhibitor antagonist or an angiotensin receptor antagonist, we found an increased frequency of in-stent restenosis in the DD genotypes (40% vs. 12%, p = 0.006). CONCLUSIONS The D/I polymorphism is not an independent predictor of coronary in-stent restenosis in general, but it may be of clinical importance in patients treated with ACE inhibitors or angiotensin receptor antagonists. (J Am Coll Cardiol 2001;38:1434-9) (C) 2001 by the American College of Cardiology.
引用
收藏
页码:1434 / 1439
页数:6
相关论文
共 36 条
[1]   ACE gene polymorphism: Ischemic heart disease and longevity in 10150 individuals - A case-referent and retrospective cohort study based on the Copenhagen City Heart Study [J].
AgerholmLarsen, B ;
Nordestgaard, BG ;
Steffensen, R ;
Sorensen, TIA ;
Jensen, G ;
TybjaergHansen, A .
CIRCULATION, 1997, 95 (10) :2358-2367
[2]  
Amant C, 1997, CIRCULATION, V96, P56
[3]  
Andersen HR, 1996, CIRCULATION, V93, P1716
[4]  
Axel DI, 1997, CIRCULATION, V96, P636
[5]  
BALCON R, 1992, CIRCULATION, V86, P100
[6]   RESTENOSIS AFTER ARTERIAL INJURY CAUSED BY CORONARY STENTING IN PATIENTS WITH DIABETES-MELLITUS [J].
CARROZZA, JP ;
KUNTZ, RE ;
FISHMAN, RF ;
BAIM, DS .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (05) :344-349
[7]   ANGIOTENSIN-CONVERTING ENZYME-INHIBITION WITH FOSINOPRIL SODIUM IN THE PREVENTION OF RESTENOSIS AFTER CORONARY ANGIOPLASTY [J].
DESMET, W ;
VROLIX, M ;
DESCHEERDER, I ;
VANLIERDE, J ;
WILLEMS, JL ;
PIESSENS, J .
CIRCULATION, 1994, 89 (01) :385-392
[8]   Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement [J].
Elezi, S ;
Kastrati, A ;
Pache, J ;
Wehinger, A ;
Hadamitzky, M ;
Dirschinger, J ;
Neumann, FJ ;
Schömig, A .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (07) :1866-1873
[9]   CORONARY MORPHOLOGICAL AND CLINICAL DETERMINANTS OF PROCEDURAL OUTCOME WITH ANGIOPLASTY FOR MULTIVESSEL CORONARY-DISEASE - IMPLICATIONS FOR PATIENT SELECTION [J].
ELLIS, SG ;
VANDORMAEL, MG ;
COWLEY, MJ ;
DISCIASCIO, G ;
DELIGONUL, U ;
TOPOL, EJ ;
BULLE, TM .
CIRCULATION, 1990, 82 (04) :1193-1202
[10]  
Emanuelsson H, 1997, J INVASIVE CARDIOL, V9, P561